Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC43321 CPTH6 (hydrobromide) A Gcn5 and pCAF HAT inhibitor
  3. GC43297 Coenzyme Q2

    辅酶Q2

    A biosynthetic precursor to CoQ10 and an inhibitor of mitochondrial complex I
  4. GC43274 Citromycetin

    柠檬菌素

    A fungal metabolite
  5. GC43273 Citreoindole A diketopiperazine metabolite
  6. GC43239 Chk2 Inhibitor

    SC-203885

    A Chk2 inhibitor
  7. GC43237 Chevalone C A fungal metabolite
  8. GC43236 Chevalone B

    A fungal metabolite

  9. GC43234 Chaetoglobosin A

    球毛壳菌素 A

    A mycotoxic cytochalasin
  10. GC43230 Ceramides (non-hydroxy) Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires the coordinated action of serine palmitoyl transferase and ceramide synthase.
  11. GC43229 Ceramide Phosphoethanolamines (bovine) Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group.
  12. GC43217 CDK/CRK Inhibitor

    Cdk7 Inhibitor IV, Cyclin-dependent kinase 7 Inhibitor IV, Cyclin-dependent kinase/CDK-related kinase Inhibitor, RGB-286147

    A CDK/CRK-specific kinase inhibitor
  13. GC43203 CAY10726 An arylurea fatty acid
  14. GC43198 CAY10717 A multi-targeted kinase inhibitor
  15. GC43190 CAY10682 A dual inhibitor of p53-Mdm2 interaction and NF-κB signaling
  16. GC43189 CAY10681 A dual modulator of p53-MDM2 interaction and NF-κB signaling
  17. GC43176 CAY10575

    IKK2 Inhibitor 3, Polo-like Kinase Inhibitor 1

    An IKKβ and Plk1 inhibitor
  18. GC43154 CAY10443

    (S)Indan1yl 3,4dichlorobenzylcarbamate

    A cytochrome c-dependent inducer of apoptosis
  19. GC43150 CAY10406 A trifluoromethyl analog of a selective caspase inhibitor
  20. GC43149 CAY10404 A COX-2 inhibitor
  21. GC43146 Caspase-9 Inhibitor III (trifluoroacetate salt)

    Ac-LEHD-CMK

    A caspase-9 inhibitor
  22. GC43144 Carfilzomib Impurity 13 (hydrochloride) A potential impurity found in commercial carfilzomib preparations
  23. GC43125 Calcein UltraBlue™ AM

    Calcein UltraBlue Acetoxymethyl ester

    A fluorogenic dye
  24. GC43123 Calcein Red™ AM

    Calcein Red Acetoxymethyl ester

    A fluorogenic dye
  25. GC43121 Calcein Orange™ Diacetate A fluorogenic dye
  26. GC43111 C8 L-threo Ceramide (d18:1/8:0)

    L-threo Cer(d18:1/8:0), L-threo Ceramide (d18:1/8:0), N-octanoyl-L-threo-Sphingosine

    A bioactive sphingolipid
  27. GC43110 C8 Galactosylceramide (d18:1/8:0)

    Galactosylceramide (d18:1/8:0), N-octanoyl-βD-Galactosylceramide, GalCer(d18:1/8:0)

    A synthetic bioactive sphingolipid
  28. GC43109 C8 D-threo Ceramide (d18:1/8:0)

    D-threo Cer(d18:1/8:0), D-threo Ceramide (d18:1/8:0), N-octanoyl-D-threo-Sphingosine

    A bioactive sphingolipid
  29. GC43105 C8 Ceramide (d18:1.8:0)

    N-辛酰基-D-神经鞘氨醇; N-Octanoyl-D-erythro-sphingosine

    A cell-permeable ceramide analog
  30. GC43084 C4 Ceramide (d18:1/4:0)

    C4酰胺,Cer(d18:1/4:0)

    A bioactive sphingolipid
  31. GC43075 C24 dihydro Ceramide (d18:0/24:0)

    Cer(d18:0/24:0)

    A sphingolipid
  32. GC43069 C22 Ceramide (d18:1/22:0)

    C22 Ceramide;Cer(d18:1/22:0);Ceramide (d18:1/22:0)

    A bioactive sphingolipid
  33. GC43065 C2 Phytoceramide (t18:0/2:0)

    N-Acetyl Phytosphingosine, C2:0 Phytoceramide, Cer(t18:0/2:0), Ceramide (t18:0/2:0), NAPS

    A bioactive sphingolipid
  34. GC43052 C18 Phytoceramide (t18:0/18:0)

    N-硬脂酰植物鞘胺醇

    A bioactive sphingolipid
  35. GC43028 C16 Ceramide (d18:1/16:0)

    N-棕榈酰神经鞘氨醇,Palmitoyl Ceramide

    C16 神经酰胺(d18:1/16:0)是一种内源性神经酰胺,由神经酰胺合成酶 6(CerS6)生成,作为脂质第二信使调控细胞凋亡和应激信号。
  36. GC42974 Brassinin

    芸苔宁,Brassinine

    An anticancer phytoalexin
  37. GC42969 bpV(phen) (potassium hydrate)

    Bisperoxovanadium(phen), Potassium Bisperoxo(1,10phenanthroline) oxovanadate (V)

    An inhibitor of phosphatases
  38. GC42953 BMS 345541 (trifluoroacetate salt) BMS 345541 is a cell permeable inhibitor of the IκB kinases IKKα and IKKβ (IC50s = 4 and 0.3 μM).
  39. GC42925 Berteroin

    5-Methylthiopentyl isothiocyanate

    A natural sulforaphane analog
  40. GC42912 Becatecarin

    NSC 655649; BMS 181176; BMY 27557

    A water-soluble antineoplastic antibiotic
  41. GC42897 BAY 61-3606 (hydrochloride) A Syk inhibitor
  42. GC42880 Avenanthramide-C methyl ester Inhibitor of NF-κB activation
  43. GC42863 Asukamycin

    AM1042, Asukamycin A

    An antitumor antibiotic
  44. GC42860 Aspochalasin D A fungal metabolite
  45. GC42858 Aspergillin PZ A fungal metabolite
  46. GC42827 Apoptolidin

    Apoptolidin A

    An apoptosis inducer and F1FO ATPase inhibitor
  47. GC42813 Anguinomycin A

    似蛇霉素A

    A leptomycin B analog
  48. GC42806 Andrastin A

    NSC 697452

    A meroterpenoid farnesyltransferase inhibitor
  49. GC42785 Amifostine (hydrate)

    氨磷汀三水合物,WR2721 trihydrate

    A broad-spectrum radioprotective thiol
  50. GC42783 Ametantrone

    阿美蒽醌,NSC 196473; NSC 290813

    An inhibitor of topoisomerase II
  51. GC42776 Amarogentin

    苦龙胆酯苷

    A secoiridoid glycoside with diverse biological activities

Items 1301 to 1350 of 2517 total

per page

Set Descending Direction